Cargando…

Serum biomarkers and anti-flavivirus antibodies at presentation as indicators of severe dengue

BACKGROUND: Dengue is the most common vector-borne viral disease worldwide. Most cases are mild, but some evolve into severe dengue (SD), with high lethality. Therefore, it is important to identify biomarkers of severe disease to improve outcomes and judiciously utilize resources. METHODS/PRINCIPAL...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernal, Cynthia, Ping, Sara, Rojas, Alejandra, Caballero, Oliver, Stittleburg, Victoria, de Guillén, Yvalena, Langjahr, Patricia, Pinsky, Benjamin A., Von-Horoch, Marta, Luraschi, Patricia, Cabral, Sandra, Sánchez, María Cecilia, Torres, Aurelia, Cardozo, Fátima, Waggoner, Jesse J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997924/
https://www.ncbi.nlm.nih.gov/pubmed/36848385
http://dx.doi.org/10.1371/journal.pntd.0010750
_version_ 1784903361089241088
author Bernal, Cynthia
Ping, Sara
Rojas, Alejandra
Caballero, Oliver
Stittleburg, Victoria
de Guillén, Yvalena
Langjahr, Patricia
Pinsky, Benjamin A.
Von-Horoch, Marta
Luraschi, Patricia
Cabral, Sandra
Sánchez, María Cecilia
Torres, Aurelia
Cardozo, Fátima
Waggoner, Jesse J.
author_facet Bernal, Cynthia
Ping, Sara
Rojas, Alejandra
Caballero, Oliver
Stittleburg, Victoria
de Guillén, Yvalena
Langjahr, Patricia
Pinsky, Benjamin A.
Von-Horoch, Marta
Luraschi, Patricia
Cabral, Sandra
Sánchez, María Cecilia
Torres, Aurelia
Cardozo, Fátima
Waggoner, Jesse J.
author_sort Bernal, Cynthia
collection PubMed
description BACKGROUND: Dengue is the most common vector-borne viral disease worldwide. Most cases are mild, but some evolve into severe dengue (SD), with high lethality. Therefore, it is important to identify biomarkers of severe disease to improve outcomes and judiciously utilize resources. METHODS/PRINCIPAL FINDINGS: One hundred forty-five confirmed dengue cases (median age, 42; range <1–91 years), enrolled from February 2018 to March 2020, were selected from an ongoing study of suspected arboviral infections in metropolitan Asunción, Paraguay. Cases included dengue virus types 1, 2, and 4, and severity was categorized according to the 2009 World Health Organization guidelines. Testing for anti-dengue virus IgM and IgG and serum biomarkers (lipopolysaccharide binding protein and chymase) was performed on acute-phase sera in plate-based ELISAs; in addition, a multiplex ELISA platform was used to measure anti-dengue virus and anti-Zika virus IgM and IgG. Complete blood counts and chemistries were performed at the discretion of the care team. Age, gender, and pre-existing comorbidities were associated with SD vs. dengue with/without warning signs in logistic regression with odds ratios (ORs) of 1.07 (per year; 95% confidence interval, 1.03, 1.11), 0.20 (female; 0.05,0.77), and 2.09 (presence; 1.26, 3.48) respectively. In binary logistic regression, for every unit increase in anti-DENV IgG in the multiplex platform, odds of SD increased by 2.54 (1.19–5.42). Platelet count, lymphocyte percent, and elevated chymase were associated with SD in a combined logistic regression model with ORs of 0.99 (1,000/μL; 0.98,0.999), 0.92 (%; 0.86,0.98), and 1.17 (mg/mL; 1.03,1.33) respectively. CONCLUSIONS: Multiple, readily available factors were associated with SD in this population. These findings will aid in the early detection of potentially severe dengue cases and inform the development of new prognostics for use in acute-phase and serial samples from dengue cases.
format Online
Article
Text
id pubmed-9997924
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-99979242023-03-10 Serum biomarkers and anti-flavivirus antibodies at presentation as indicators of severe dengue Bernal, Cynthia Ping, Sara Rojas, Alejandra Caballero, Oliver Stittleburg, Victoria de Guillén, Yvalena Langjahr, Patricia Pinsky, Benjamin A. Von-Horoch, Marta Luraschi, Patricia Cabral, Sandra Sánchez, María Cecilia Torres, Aurelia Cardozo, Fátima Waggoner, Jesse J. PLoS Negl Trop Dis Research Article BACKGROUND: Dengue is the most common vector-borne viral disease worldwide. Most cases are mild, but some evolve into severe dengue (SD), with high lethality. Therefore, it is important to identify biomarkers of severe disease to improve outcomes and judiciously utilize resources. METHODS/PRINCIPAL FINDINGS: One hundred forty-five confirmed dengue cases (median age, 42; range <1–91 years), enrolled from February 2018 to March 2020, were selected from an ongoing study of suspected arboviral infections in metropolitan Asunción, Paraguay. Cases included dengue virus types 1, 2, and 4, and severity was categorized according to the 2009 World Health Organization guidelines. Testing for anti-dengue virus IgM and IgG and serum biomarkers (lipopolysaccharide binding protein and chymase) was performed on acute-phase sera in plate-based ELISAs; in addition, a multiplex ELISA platform was used to measure anti-dengue virus and anti-Zika virus IgM and IgG. Complete blood counts and chemistries were performed at the discretion of the care team. Age, gender, and pre-existing comorbidities were associated with SD vs. dengue with/without warning signs in logistic regression with odds ratios (ORs) of 1.07 (per year; 95% confidence interval, 1.03, 1.11), 0.20 (female; 0.05,0.77), and 2.09 (presence; 1.26, 3.48) respectively. In binary logistic regression, for every unit increase in anti-DENV IgG in the multiplex platform, odds of SD increased by 2.54 (1.19–5.42). Platelet count, lymphocyte percent, and elevated chymase were associated with SD in a combined logistic regression model with ORs of 0.99 (1,000/μL; 0.98,0.999), 0.92 (%; 0.86,0.98), and 1.17 (mg/mL; 1.03,1.33) respectively. CONCLUSIONS: Multiple, readily available factors were associated with SD in this population. These findings will aid in the early detection of potentially severe dengue cases and inform the development of new prognostics for use in acute-phase and serial samples from dengue cases. Public Library of Science 2023-02-27 /pmc/articles/PMC9997924/ /pubmed/36848385 http://dx.doi.org/10.1371/journal.pntd.0010750 Text en © 2023 Bernal et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Bernal, Cynthia
Ping, Sara
Rojas, Alejandra
Caballero, Oliver
Stittleburg, Victoria
de Guillén, Yvalena
Langjahr, Patricia
Pinsky, Benjamin A.
Von-Horoch, Marta
Luraschi, Patricia
Cabral, Sandra
Sánchez, María Cecilia
Torres, Aurelia
Cardozo, Fátima
Waggoner, Jesse J.
Serum biomarkers and anti-flavivirus antibodies at presentation as indicators of severe dengue
title Serum biomarkers and anti-flavivirus antibodies at presentation as indicators of severe dengue
title_full Serum biomarkers and anti-flavivirus antibodies at presentation as indicators of severe dengue
title_fullStr Serum biomarkers and anti-flavivirus antibodies at presentation as indicators of severe dengue
title_full_unstemmed Serum biomarkers and anti-flavivirus antibodies at presentation as indicators of severe dengue
title_short Serum biomarkers and anti-flavivirus antibodies at presentation as indicators of severe dengue
title_sort serum biomarkers and anti-flavivirus antibodies at presentation as indicators of severe dengue
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997924/
https://www.ncbi.nlm.nih.gov/pubmed/36848385
http://dx.doi.org/10.1371/journal.pntd.0010750
work_keys_str_mv AT bernalcynthia serumbiomarkersandantiflavivirusantibodiesatpresentationasindicatorsofseveredengue
AT pingsara serumbiomarkersandantiflavivirusantibodiesatpresentationasindicatorsofseveredengue
AT rojasalejandra serumbiomarkersandantiflavivirusantibodiesatpresentationasindicatorsofseveredengue
AT caballerooliver serumbiomarkersandantiflavivirusantibodiesatpresentationasindicatorsofseveredengue
AT stittleburgvictoria serumbiomarkersandantiflavivirusantibodiesatpresentationasindicatorsofseveredengue
AT deguillenyvalena serumbiomarkersandantiflavivirusantibodiesatpresentationasindicatorsofseveredengue
AT langjahrpatricia serumbiomarkersandantiflavivirusantibodiesatpresentationasindicatorsofseveredengue
AT pinskybenjamina serumbiomarkersandantiflavivirusantibodiesatpresentationasindicatorsofseveredengue
AT vonhorochmarta serumbiomarkersandantiflavivirusantibodiesatpresentationasindicatorsofseveredengue
AT luraschipatricia serumbiomarkersandantiflavivirusantibodiesatpresentationasindicatorsofseveredengue
AT cabralsandra serumbiomarkersandantiflavivirusantibodiesatpresentationasindicatorsofseveredengue
AT sanchezmariacecilia serumbiomarkersandantiflavivirusantibodiesatpresentationasindicatorsofseveredengue
AT torresaurelia serumbiomarkersandantiflavivirusantibodiesatpresentationasindicatorsofseveredengue
AT cardozofatima serumbiomarkersandantiflavivirusantibodiesatpresentationasindicatorsofseveredengue
AT waggonerjessej serumbiomarkersandantiflavivirusantibodiesatpresentationasindicatorsofseveredengue